Skip to main content

Table 1 Demographics of all treated patients

From: Lanthanum carbonate for the treatment of hyperphosphatemia in CKD 5D: multicenter, double blind, randomized, controlled trial in mainland China

Items

Classification

Lanthanum carbonate (n=114)

Placebo (n=113)

P value

Age (y)

 

47.6 (13.0)

48.4 (11.7)

0.761

Gender

Male

60 (52.6)

72 (63.7)

0.090

 

Female

54 (47.4)

41 (36.3)

 

Ethnicity

Han

112 (98.2)

111 (98.2)

1.000

 

Other

2 (1.7)

2 (1.8)

 

Height (cm)

 

165.7 (7.7)

165.9 (7.6)

0.674

Post-dialysis weight (kg)

 

60.9 (12.1)

61.9 (10.8)

0.342

Dialysis mode

Hemodialysis

82 (72.0)

82 (72.6)

0.915

 

Peritoneal dialysis

32 (28.1)

31 (27.4)

 

Hemodialysis frequency (per week)

 

2.9 (0.3)

2.8 (0.3)

0.553

Hemodialysis time (hr)

 

4.1 (0.3)

4.1 (0.3)

0.460

Total volume of peritoneal dialysate (ml)

 

7951.2 (1208.0)

7983.9 (1369.2)

0.839

Heart failure

 

4 (3.5)

2 (1.8)

0.683